Possible role of AP1 transcription factor in tissue-specific regulation of human papillomavirus

Revista de Investigacion Clinica

Volumn 54, Issue 3, 2002, Pages 231-242

  Velazquez Torres, Araceli ^a   Gariglio Vidal, Patricio ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

AP1; HPV; Tissue specific transcription; Transcription factors; Transcriptional regulation

Indexed keywords

DIMER; DNA BINDING PROTEIN; GROWTH FACTOR; LEUCINE ZIPPER PROTEIN; METALLOTHIONEIN; MITOGENIC AGENT; ONCOPROTEIN; PROTEIN C JUN; PROTEIN FOS; RETINOIC ACID; TRANSCRIPTION FACTOR AP 1; IMMEDIATE EARLY PROTEIN; PROTEIN KINASE; VIRUS PROTEIN;

ARTICLE; BASAL CELL; CELL DIFFERENTIATION; CELL LINE; CELL MIGRATION; CELL TRANSFORMATION; CONTROLLED STUDY; DNA VIRUS; ENHANCER REGION; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENE TARGETING; GENETIC CODE; GENOME; GENOTYPE; INFECTION RISK; MUTAGENESIS; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; TISSUE SPECIFICITY; UTERINE CERVIX CANCER; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS INFECTION; VIRUS ONCOGENE; WART VIRUS; ANTIBODY SPECIFICITY; BIOLOGICAL MODEL; BIOSYNTHESIS; CLASSIFICATION; EPITHELIUM CELL; FEMALE; GENETIC TRANSCRIPTION; GENETICS; HUMAN; IMMEDIATE EARLY GENE; METABOLISM; PAPILLOMA VIRUS; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN PROCESSING; REVIEW; UTERINE CERVIX TUMOR; UTERUS CANCER; VIROLOGY; VIRUS REPLICATION;

EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, VIRAL; GENES, IMMEDIATE-EARLY; GENES, VIRAL; HUMANS; IMMEDIATE-EARLY PROTEINS; MODELS, BIOLOGICAL; MUTAGENESIS; ONCOGENE PROTEINS, VIRAL; ORGAN SPECIFICITY; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); PROTEIN KINASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; UTERINE NEOPLASMS; VIRAL STRUCTURAL PROTEINS; VIRUS REPLICATION;

EID: 0036049479     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (78)

1. Papillomavirus: Retrospectives and prospectives
2. Cáncer cervicouterino
3. Infección por el virus del papiloma humano y cáncer cérvico-uterino
4. Papillomaviruses in anogenital cancer as a model to understand the roles of viruses in human cancers
5. Genital human papillomavirus infection in female university students as determined by a PCR-based method
6. Persistence of type-specific human papillomavirus infection among citologically normal women
7. HPV and cervical neoplasia: Review of case-control and short studies
8. Analysis of physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm
9. Interplay of viral and cellular proteins along the long control region of human papillomavirus type 18
10. Amplification of human papillomavirus (HPV) oncogene expression: Composition of the HPV types 18 upstream regulatory region
11. Human papillomavirus type 6 and 11 mRNAs from genital condylomata acuminata
12. Characterization of human papillomavirus type 11 E1 and E2 proteins expressed in insect cells
13. Transcription of the transforming genes of the oncogenic human papillomavirus type 16 is stimulated by tumor promoters through AP-1 binding sites
14. The enhancer of human papillomavirus type 16: Binding sites for the ubiquitous transcription factors oct-1, NFA, TEF-2, NF1 and AP-1 participate in epithelial call specific transcription
15. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus positive and negative squamous cell carcinoma of the anus
16. The mouse p44 mitogenic activated protein kinase (extracellular signal regulated kinase-1) gene
17. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product
18. Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoprotein of the human papilloma-viruses
19. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes
20. Complex formation of human papillomavirus E7 proteins with retinoblastoma tumor suppressor gene product
21. Differential induction and regulation of c-jun, junB, junD and c-fos by human papillomavirus type 11 E5a oncoprotein
22. Association of human papillomavirus types 16 and 18 E6 proteins with p53
23. The E7 protein of papillomavirus type 16 is phosphorilated by casein kinase II
24. The regulation mechanism of c-jun and junB by human papillomavirus type 16 E5 oncoprotein
25. The E5 gene from human papillomavirus type 16 is an oncogene which enhances growth factor-mediated signal transduction to the nucleus
26. Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor
27. Comparative analysis of cellular and tisular expression of c-fos in human keratinocytes: Evidence of its role in cell differentiation
28. The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes
29. Human papillomaviruses. Transcription factor binding sites in the long control region of genital HPVs
30. Multiple interactions between cellular factors and the non-coding region of human papillomavirus type 16
31. Characterization of a transcriptional promoter of human papillomavirus 18 and modulation of its expression by simian virus 40 and adenovirus early antigens
32. Regulatory mechanisms of the papillomaviruses
33. Transcription activities of human papillomavirus type 11 E6 promoter-proximal elements in raft and submerged cultures of foreskin keratinocytes
34. Differentiation- induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes
35. Numerous nuclear factors bind the long control region of human papillomavirus type 16: A subset of 6 out of 23 DNase I-protected segments coincides with the location of the cell-type-specific enhancer
36. Effect of AP-1 transcription factors on the regulation of transcription in normal human epidermal keratinocytes
37. Activator protein 1 activity is involved in the regulation of the cell type-specific expression from the proximal promoter of the human profilagrin gene
38. A Keratinocyte-specific transcription factor, KRF, interacts with AP-1 to activate expression of human papillomavirus type 1 in squamous epithelial cells
39. YY1 repress human papillomavirus type 16 transcription by quenching AP-1 activity
40. The structure, function and regulation of papillomaviral genes in infection and cervical cancer
41. Induction of the HPV16 enhancer activity by Jun-B and c-Fos through cooperation of the promoter-proximal AP-1 site and the epithelial cell type-specific regulatory element in fibroblasts
42. Differential regulation by c-jun and c-fos protooncogenes of hormone response from composite glucocorticoid response element in human papillomavirus type 16 regulatory region
43. A member of the activator protein 1 family found in keratinocytes but not in fibroblasts required for transcription from a human papillomavirus type 18 promoter
44. An enhanced epithelial response of a papillomavirus promoter to transcriptional activators
45. The cornified cell envelope: A key structure of terminally differentiating keratinocytes
46. Differential expression pattern of the three fringe genes is associated with epidermal differentiation
47. Elements controlling the expression and induction of the skin hiperproliferation-associated keratin K6
48. Transcriptional activity of human papillomavirus type 31b enhancer is regulated though synergistic interaction of AP-1 with two novel factors
49. Expression of AP-1 during cellular differentiation determines human papillomavirus E6/E7 expression in stratified epithelial cells
50. Two AP1 sites binding Jun B are essential for human papillomavirus type 18 transcription in keratinocytes
51. Constitutive transcriptional activator of epidermodysplasia verruciformis-associated human papillomavirus 8
52. Metal-responsive elements act as positive modulators of human metalothionein-IIA enhancer activity
53. Upstream promoter element of the human metallothionein IIa gene can ant like an enhancer element
54. Nuclear protooncogenes Fos and Jun
55. CREB: A Ca 2+-regulated transcription factor phosphorylated by calmodulin-dependent kinases
56. The regulation of AP-1 activity by mitogen-activated protein kinases
57. Phosphorylation of c-jun mediated by MAP kinases
58. c-Jun N-terminal phosphorilation correlates with activation of the JNK subgroup of mitogen-activated protein kinases
59. Casein kinase II is a negative regulator of c-Jun DNA binding and AP-1 activity
60. junD mRNA expression differs from c-jun and junB mRNA expression during male germinal cell differentiation
61. Differential expression of fos and jun family members during murine postnatal intestinal development
62. AP-1 activity during normal human keratinocyte differentiation: Evidence for a cytosolic modulator of AP-1/DNA binding
63. Selective expression of fos- and jun-related genes during osteoblasts proliferation and differentiation
64. Expression of fos and jun genes in human skeletal muscle after exercise
65. Changes in the expression of members of the fos and jun families and Myc network during terminal differentiation of human keratinocytes
66. Differential expression of the fos and jun family members: C-fos, fosB, fra-1, fra-2, c-jun, jun-B and jun D during human epidermal keratinocytes differentiation
67. Fos related antigen (Fra-1), JunB and Jun D activate human involucrin promoter transcription by binding to proximal and distal AP-1 sites to mediate phorbol ester effects on promoter activity
68. Epidermal differentiation: The bare essentials
69. Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblasts hybrids to invasive growth involves loss of TNF-β mediated repression of viral transcription and modification of the AP-1 transcription complex
70. Differential regulation of c-fos, fosB, c-jun, junB, bcl-2 and bax expression in rat skin following single or chronic ultraviolet irradiation and in vivo modulation by antisense oligodeoxynucleotide superfusion
71. High levels of c-fos proto-oncogene expression in normal human adult skin
72. The distal regulatory region of the human involucrin promoter is required for expression in Epidermis
73. The proximal promoter of the mouse loricrin gene contains a functional AP-1 element and directs keratinocyte-specific but not differentiation-specific expression
74. Trichostatin a up-regulates human papillomavirus type II upstream regulatory region-E6 promoter activity in undifferentiated primary human keratinocytes
75. Regions of human papillomavirus type 16 E7 oncoprotein required for inmortalization of human keratinocytes
76. The human papillomavirus type 16 E7 gene product interacts with and trans-activates the AP-1 Family of transcription factors
77. Topical retinoic acid reduces skin papilloma formation but resistant papillomas are at high risk for malignant conversion
78. Bloking activator protein-1 activity, but not activating retinoic acid response element, is required for the antitumor promotion effect of retinoic acid